Dopamine Receptor D5 (DRD5) (NM_000798) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC202502L4V
- LentiORF®
-
Lenti ORF particles, DRD5 (mGFP-tagged) - Human dopamine receptor D5 (DRD5), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 9,975.00
货期*
详询
规格
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
经常一起买 (3)
Specifications
Product Data | |
Product Name | Dopamine Receptor D5 (DRD5) (NM_000798) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | DBDR; DRD1B; DRD1L2 |
Vector | pLenti-C-mGFP-P2A-Puro |
ACCN | NM_000798 |
ORF Size | 1431 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC202502).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_000798.3, NP_000789.1 |
RefSeq Size | 2398 bp |
RefSeq ORF | 1434 bp |
Locus ID | 1816 |
Protein Families | Druggable Genome, GPCR, Transmembrane |
Protein Pathways | Calcium signaling pathway, Neuroactive ligand-receptor interaction |
MW | 53 kDa |
Gene Summary | This gene encodes the D5 subtype of the dopamine receptor. The D5 subtype is a G-protein coupled receptor which stimulates adenylyl cyclase. This receptor is expressed in neurons in the limbic regions of the brain. It has a 10-fold higher affinity for dopamine than the D1 subtype. Pseudogenes related to this gene reside on chromosomes 1 and 2. [provided by RefSeq, Jul 2008] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
其它Dopamine Receptor D5产品
Customer
Reviews
Loading...